← Leaderboards
Dan M Roden
Vanderbilt University Medical Center
$145,793,078
Attributed
$378,351,382
Total exposure
31
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $85.4M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$399,431,489 · 33
By mechanism
OT2$188,304,619 · 1
U2C$87,772,952 · 1
U01$48,893,596 · 6
P50$19,622,821 · 3
R01$18,216,500 · 5
U19$17,411,793 · 1
Top collaborators
- David Glazer18 shared
- Paul A. Harris18 shared
- Joshua C. Denny14 shared
- Anthony Philippakis12 shared
- Melissa Basford11 shared
- Elizabeth Phillips8 shared
- Wei-Qi Wei7 shared
- Lee Lichtenstein6 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Wei-Qi Wei$9,737,275
- Sunil Kripalani$10,616,100
- Alexander Bick$5,781,681
- Margaret McCullough Benningfield$498,339
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeResourcesGenomicsPharmaceutical PreparationsVariantResearch PersonnelArrhythmiaResponseVisionLinkComputerized Medical RecordGeneticSiteGenesBaseCohortPharmacogenomicsProgramsHeart RhythmGenotypeSamplingCommunitiesPhenomeData Set
Grant awards (149)
All of Us Research Program Data and Research Center$40,678,454
OT2 · FY2025 · OD
All of Us Research Program Data and Research Center$25,000,000
OT2 · FY2025 · OD
All of Us Research Program Data and Research Center$10,920,000
OT2 · FY2025 · OD
All of Us Research Program Data and Research Center$2,500,000
OT2 · FY2025 · OD
Systematically mapping variant effects for cardiovascular genes$2,019,687
R01 · FY2025 · HL · contact PI
All of Us Research Program Data and Research Center$1,950,000
OT2 · FY2025 · OD
All of Us Research Program Data and Research Center$1,250,000
OT2 · FY2025 · OD
Vanderbilt Genomic Learning Health System Clinical Site$717,381
U01 · FY2025 · HG · contact PI
VGM: Vanderbilt Genomic Medicine Training Program$362,422
T32 · FY2025 · HG
All of Us Research Program Data and Research Center$44,890,442
OT2 · FY2024 · OD
All of Us Research Program Data and Research Center$4,120,558
OT2 · FY2024 · OD
All of Us Research Program Data and Research Center$2,500,000
OT2 · FY2024 · OD
Systematically mapping variant effects for cardiovascular genes$1,983,411
R01 · FY2024 · HL · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$749,397
U01 · FY2024 · HG · contact PI
Vanderbilt Genomic Learning Health System Clinical Site$734,123
U01 · FY2024 · HG · contact PI
VGM: Vanderbilt Genomic Medicine Training Program$33,126
T32 · FY2024 · HG
All of Us Research Program Data and Research Center$51,995,165
OT2 · FY2023 · OD
All of Us Research Program Data and Research Center$2,500,000
OT2 · FY2023 · OD
Systematically mapping variant effects for cardiovascular genes$2,027,154
R01 · FY2023 · HL · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$1,367,395
U01 · FY2023 · HG · contact PI
Functional Genomics of Cardiac Sodium Channel Variants$735,432
R01 · FY2023 · HL · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$106,629
U01 · FY2023 · HG · contact PI
VGM: Vanderbilt Genomic Medicine Training Program$25,000
T32 · FY2023 · HG
Data and Research Support Center$12,889,425
U2C · FY2022 · OD
Data and Research Support Center$10,311,540
U2C · FY2022 · OD
Enhancing All of Us Data Resources for Nutrition Precision Health: the All of Us Data and Research Center$3,000,000
U2C · FY2022 · OD
Systematically mapping variant effects for cardiovascular genes$2,085,976
R01 · FY2022 · HL · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$1,448,100
U01 · FY2022 · HG · contact PI
Functional Genomics of Cardiac Sodium Channel Variants$731,285
R01 · FY2022 · HL · contact PI
VGM: Vanderbilt Genomic Medicine Training Program$337,009
T32 · FY2022 · HG
Data and Research Support Center$15,057,881
U2C · FY2021 · OD
Data and Research Support Center$11,013,471
U2C · FY2021 · OD
Vanderbilt Genome-Electronic Records (VGER) Project$1,448,100
U01 · FY2021 · HG · contact PI
Functional Genomics of Cardiac Sodium Channel Variants$730,945
R01 · FY2021 · HL · contact PI
VGM: Vanderbilt Genomic Medicine Training Program$321,587
T32 · FY2021 · HG
Data and Research Support Center$24,489,496
U2C · FY2020 · OD
Data and Research Support Center$11,011,139
U2C · FY2020 · OD
Vanderbilt Genome-Electronic Records (VGER) Project$1,091,018
U01 · FY2020 · HG · contact PI
Functional Genomics of Cardiac Sodium Channel Variants$732,233
R01 · FY2020 · HL · contact PI
Improving Prediction of Drug Action$2,616,904
P50 · FY2019 · GM · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$704,230
U01 · FY2019 · HG · contact PI
Analytical and Administrative Support$621,924
P50 · FY2019 · GM · contact PI
A new paradigm for identifying patients and drugs at risk for QT prolongation$617,608
P50 · FY2019 · GM · contact PI
Improving Prediction of Drug Action$2,592,271
P50 · FY2018 · GM · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$998,644
U01 · FY2018 · HG · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$838,369
U01 · FY2018 · HG · contact PI
A new paradigm for identifying patients and drugs at risk for QT prolongation$653,150
P50 · FY2018 · GM · contact PI
Analytical and Administrative Support$622,185
P50 · FY2018 · GM · contact PI
Improving Prediction of Drug Action$2,584,732
P50 · FY2017 · GM · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$779,116
U01 · FY2017 · HG · contact PI
A new paradigm for identifying patients and drugs at risk for QT prolongation$620,879
P50 · FY2017 · GM · contact PI
Analytical and Administrative Support$569,908
P50 · FY2017 · GM · contact PI
SCN5A mutations and dilated cardiomyopathy$395,000
R01 · FY2017 · HL · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$41,487
U01 · FY2017 · HG · contact PI
Improving Prediction of Drug Action$2,564,195
P50 · FY2016 · GM · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$838,369
U01 · FY2016 · HG · contact PI
A new paradigm for identifying patients and drugs at risk for QT prolongation$614,468
P50 · FY2016 · GM · contact PI
Analytical and Administrative Support$564,029
P50 · FY2016 · GM · contact PI
SCN5A mutations and dilated cardiomyopathy$392,500
R01 · FY2016 · HL · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$85,328
U01 · FY2016 · HG · contact PI
Improving Prediction of Drug Action$44,613
P50 · FY2016 · GM · contact PI
Improving Prediction of Drug Action$15,769
P50 · FY2016 · GM · contact PI
Improving Prediction of Drug Action$1,377,542
P50 · FY2015 · GM · contact PI
Improving Prediction of Drug Action$1,178,358
P50 · FY2015 · GM · contact PI
VGER, the Vanderbilt Genome-Electronic Records Project$838,369
U01 · FY2015 · HG · contact PI
Analytical and Administrative Support$568,400
P50 · FY2015 · GM · contact PI
A new paradigm for identifying patients and drugs at risk for QT prolongation$556,661
P50 · FY2015 · GM · contact PI
Modulation of Cardiac Repolarization$404,544
R01 · FY2015 · HL · contact PI
SCN5A mutations and dilated cardiomyopathy$386,612
R01 · FY2015 · HL · contact PI
A new paradigm for identifying patients and drugs at risk for QT prolongation$344,059
P50 · FY2015 · GM · contact PI
Analytical and Administrative Support$295,166
P50 · FY2015 · GM · contact PI
Pharmacogenomics of Arrhythmia Therapy$2,285,709
U19 · FY2014 · HL · contact PI
Pharmacogenomics of Arrhythmia Therapy$1,156,635
U19 · FY2014 · HL · contact PI
Vanderbilt Genome Electronic Records Project$994,819
U01 · FY2014 · HG · contact PI
Modulation of Cardiac Repolarization$405,881
R01 · FY2014 · HL · contact PI
SCN5A mutations and dilated cardiomyopathy$390,402
R01 · FY2014 · HL · contact PI
BioVU Plasma Storage Equipment$239,490
S10 · FY2014 · OD · contact PI
Pharmacogenomics of Arrhythmia Therapy$3,343,989
U19 · FY2013 · HL · contact PI
Vanderbilt Genome Electronic Records Project$1,016,001
U01 · FY2013 · HG · contact PI
Modulation of Cardiac Repolarization$381,894
R01 · FY2013 · HL · contact PI
Vanderbilt Genome Electronic Records Project$198,732
U01 · FY2013 · HG · contact PI
Pharmacogenomics of Arrhythmia Therapy$3,512,594
U19 · FY2012 · HL · contact PI
Vanderbilt Genome Electronic Records Project$764,065
U01 · FY2012 · HG · contact PI
Modulation of Cardiac Repolarization$396,513
R01 · FY2012 · HL · contact PI
Vanderbilt Genome Electronic Records Project$189,710
U01 · FY2012 · HG · contact PI
Pharmacogenomics of Arrhythmia Therapy$3,532,824
U19 · FY2011 · HL · contact PI
Vanderbilt Genome Electronic Records Project$772,709
U01 · FY2011 · HG · contact PI
Modulation of Cardiac Repolarization$383,750
R01 · FY2011 · HL · contact PI
Vanderbilt Genome Electronic Records Project$111,595
U01 · FY2011 · HG · contact PI
Vanderbilt Genome-Electronic Records Project$13,000
U01 · FY2011 · HG · contact PI
Pharmacogenomics of Arrhythmia Therapy$3,580,042
U19 · FY2010 · HL · contact PI
Vanderbilt Genome-Electronic Records Project$1,717,974
U01 · FY2010 · HG · contact PI
VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment$1,221,591
RC2 · FY2010 · GM · contact PI
Modulation of Cardiac Repolarization$383,750
R01 · FY2010 · HL · contact PI
Automated DNA Extraction for Small Volume Samples Enabling Pediatric Biobanking$139,485
S10 · FY2010 · RR · contact PI
VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment$5,184,612
RC2 · FY2009 · GM
Pharmacogenomics of Arrhythmia Therapy$2,772,165
U01 · FY2009 · HL · contact PI
Vanderbilt Genome-Electronic Records Project$1,657,952
U01 · FY2009 · HG · contact PI
Vanderbilt Genome-Electronic Records Project$415,228
U01 · FY2009 · HG · contact PI
Modulation of Cardiac Repolarization$383,750
R01 · FY2009 · HL · contact PI
Vanderbilt Genome-Electronic Records Project$229,436
U01 · FY2009 · HG · contact PI
Pharmacogenomics of Arrhythmia Therapy$2,658,629
U01 · FY2008 · HL · contact PI
Vanderbilt Genome-Electronic Records Project$1,628,531
U01 · FY2008 · HG · contact PI
Automated Storage and Retrieval of Biological Systems$988,312
S10 · FY2008 · RR · contact PI
Modulation of Cardiac Repolarization$383,750
R01 · FY2008 · HL · contact PI
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY - DRUG CHALLENGE IN HEALTHY SIB-PAIRS$738
M01 · FY2008 · RR · contact PI
Pharmacogenomics of Arrhythmia Therapy$2,644,284
U01 · FY2007 · HL · contact PI
Vanderbilt Genome-Electronic Records Project$1,588,449
U01 · FY2007 · HG · contact PI
Modulation of Cardiac Repolarization$344,907
R01 · FY2007 · HL · contact PI
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY - DRUG CHALLENGE IN HEALTHY SIB-PAIRS$15,662
M01 · FY2007 · RR · contact PI
Pharmacogenomics of Arrhythmia Therapy$2,647,864
U01 · FY2006 · HL · contact PI
Biology of Arrhythmia Susceptibility$1,233,803
P01 · FY2006 · HL · contact PI
Hepatic Drug Transporters in Drug Disposition$446,922
R01 · FY2006 · GM · contact PI
Reduced sodium channel availability and arrhythmogenesis$180,499
P01 · FY2006 · HL · contact PI
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY - DRUG CHALLENGE IN HEALTHY SIB-PAIRS$49,918
M01 · FY2006 · RR · contact PI
Pharmacogenomics of Arrhythmia Therapy$2,896,480
U01 · FY2005 · HL
Biology of Arrhythmia Susceptibility$1,225,036
P01 · FY2005 · HL
Modulation for Cardiac Repolarization$302,000
R01 · FY2005 · HL
Reduced sodium channel availability and arrhythmogenesis$175,005
P01 · FY2005 · HL
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY - DRUG CHALLENGE IN HEALTHY SIB-PAIRS$63,094
M01 · FY2005 · RR
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY$2,836,953
U01 · FY2004 · HL
Biology of Arrhythmia Susceptibility$1,174,596
P01 · FY2004 · HL
Modulation for Cardiac Repolarization$302,000
R01 · FY2004 · HL
Pharmacogenomics of Arrhythmia Therapy - Drug Challenge in Healthy Sib-Pairs$127,645
M01 · FY2004 · RR
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY$2,776,081
U01 · FY2003 · HL
Biology of Arrhythmia Susceptibility$1,138,952
P01 · FY2003 · HL
Clinical Pharmacology Training Program$378,076
T32 · FY2003 · GM
Modulation for Cardiac Repolarization$302,000
R01 · FY2003 · HL
Molecular Pathology of Cardic Arrhythmias$10,000
R13 · FY2003 · HL
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY$2,761,785
U01 · FY2002 · HL
Biology of Arrhythmia Susceptibility$1,128,663
P01 · FY2002 · HL
Modulation for Cardiac Repolarization$302,000
R01 · FY2002 · HL
Clinical Pharmacology Training Program$290,532
T32 · FY2002 · GM
Reduced sodium channel availability and arrhythmogenesis$161,237
P01 · FY2002 · HL
FEXOFENADINE IN GASTROINTESTINAL TRACT BY DIETARY SODIUM$0
M01 · FY2002 · RR
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY$2,815,099
U01 · FY2001 · HL
HETEROGENEITY IN CARDIAC POTASSIUM CHANNEL FUNCTION$1,129,822
P01 · FY2001 · HL
CLINICAL PHARMACOLOGY TRAINING PROGRAM$371,547
T32 · FY2001 · GM
MODULATION OF CARDIAC REPOLARIZATION$243,808
R01 · FY2001 · HL
CELLULAR LOCALIZATION OF CARDIAC ION CHANNELS$186,552
P01 · FY2001 · HL
FEXOFENADINE IN GASTROINTESTINAL TRACT BY DIETARY SODIUM$0
M01 · FY2001 · RR
FEXOFENADINE IN GASTROINTESTINAL TRACT BY DIETARY SODIUM$0
M01 · FY2001 · RR
FEXOFENADINE IN GASTROINTESTINAL TRACT BY DIETARY SODIUM$0
M01 · FY2001 · RR
HETEROGENEITY IN CARDIAC POTASSIUM CHANNEL FUNCTION$1,074,851
P01 · FY2000 · HL
MODULATION OF CARDIAC REPOLARIZATION$238,394
R01 · FY2000 · HL
CELLULAR LOCALIZATION OF CARDIAC ION CHANNELS$212,504
P01 · FY2000 · HL
CLINICAL PHARMACOLOGY TRAINING PROGRAM$27,250
T32 · FY2000 · GM
DIETARY SALT AND DRUG DISPOSITION$592
M01 · FY2000 · RR
FEXOFENADINE IN GASTROINTESTINAL TRACT BY DIETARY SODIUM$0
M01 · FY2000 · RR